臓器移植用免疫抑制薬の世界市場2021年

QYResearchが発行した調査報告書(QYR21JN7817)
◆英語タイトル:Global Organ Transplant Immunosuppressant Sales Market Report 2021
◆商品コード:QYR21JN7817
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:146
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥660,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の臓器移植用免疫抑制薬市場について種類別(タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他)、用途別(肝移植、腎臓移植、心臓移植、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・臓器移植用免疫抑制薬市場の概要
・世界の主要地域別臓器移植用免疫抑制薬市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の臓器移植用免疫抑制薬市場規模2016-2021:種類別(タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他)
・世界の臓器移植用免疫抑制薬市場予測2012-2027:種類別(タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他)
・世界の臓器移植用免疫抑制薬市場規模2016-2021:用途別(肝移植、腎臓移植、心臓移植、その他)
・世界の臓器移植用免疫抑制薬市場予測2012-2027:用途別(肝移植、腎臓移植、心臓移植、その他)
・臓器移植用免疫抑制薬のアメリカ市場規模と予測2016-2021
・臓器移植用免疫抑制薬のヨーロッパ市場規模と予測2016-2021
・臓器移植用免疫抑制薬の中国市場規模と予測2016-2021
・臓器移植用免疫抑制薬の日本市場規模と予測2016-2021
・臓器移植用免疫抑制薬の東南アジア市場規模と予測2016-2021
・臓器移植用免疫抑制薬のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Roche、Astellas Pharma Inc.、Huadong Pharmaceutical、Novartis、Catalent Pharma、Cinkate Corporation、Cilag、Genzyme、Changzhou Pharm、North China Pharmaceutical Group Corporation、SL PHARM、Livzon Pharmaceutical Group Inc.,、Sirio Pharma Co., Ltd)
・臓器移植用免疫抑制薬の製造コスト分析
・販売チャネル、流通業者、顧客
・臓器移植用免疫抑制薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Organ Transplant Immunosuppressant Market
The global Organ Transplant Immunosuppressant market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Organ Transplant Immunosuppressant Scope and Market Size
The global Organ Transplant Immunosuppressant market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Organ Transplant Immunosuppressant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Tacrolimus
Mycophenolate Mofetil
Cyclosporin
Others

Segment by Application
Liver Transplant
Kidney Transplant
Heart Transplant
Other Organ Transplant

The Organ Transplant Immunosuppressant market is analysed and market size information is provided by regions (countries). Segment by Application, the Organ Transplant Immunosuppressant market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Roche
Astellas Pharma Inc.
Huadong Pharmaceutical
Novartis
Catalent Pharma
Cinkate Corporation
Cilag
Genzyme
Changzhou Pharm
North China Pharmaceutical Group Corporation
SL PHARM
Livzon Pharmaceutical Group Inc.,
Sirio Pharma Co., Ltd

【レポートの目次】

1 Organ Transplant Immunosuppressant Market Overview
1.1 Organ Transplant Immunosuppressant Product Scope
1.2 Organ Transplant Immunosuppressant Segment by Type
1.2.1 Global Organ Transplant Immunosuppressant Sales by Type (2016 & 2021 & 2027)
1.2.2 Tacrolimus
1.2.3 Mycophenolate Mofetil
1.2.4 Cyclosporin
1.2.5 Others
1.3 Organ Transplant Immunosuppressant Segment by Application
1.3.1 Global Organ Transplant Immunosuppressant Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Liver Transplant
1.3.3 Kidney Transplant
1.3.4 Heart Transplant
1.3.5 Other Organ Transplant
1.4 Organ Transplant Immunosuppressant Market Estimates and Forecasts (2016-2027)
1.4.1 Global Organ Transplant Immunosuppressant Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Organ Transplant Immunosuppressant Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Organ Transplant Immunosuppressant Price Trends (2016-2027)

2 Organ Transplant Immunosuppressant Estimates and Forecasts by Region
2.1 Global Organ Transplant Immunosuppressant Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Organ Transplant Immunosuppressant Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Organ Transplant Immunosuppressant Sales Market Share by Region (2016-2021)
2.2.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Region (2016-2021)
2.3 Global Organ Transplant Immunosuppressant Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Organ Transplant Immunosuppressant Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Organ Transplant Immunosuppressant Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Organ Transplant Immunosuppressant Estimates and Projections (2016-2027)
2.4.2 Europe Organ Transplant Immunosuppressant Estimates and Projections (2016-2027)
2.4.3 China Organ Transplant Immunosuppressant Estimates and Projections (2016-2027)
2.4.4 Japan Organ Transplant Immunosuppressant Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Organ Transplant Immunosuppressant Estimates and Projections (2016-2027)
2.4.6 India Organ Transplant Immunosuppressant Estimates and Projections (2016-2027)
3 Global Organ Transplant Immunosuppressant Competition Landscape by Players
3.1 Global Top Organ Transplant Immunosuppressant Players by Sales (2016-2021)
3.2 Global Top Organ Transplant Immunosuppressant Players by Revenue (2016-2021)
3.3 Global Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant as of 2020)
3.4 Global Organ Transplant Immunosuppressant Average Price by Company (2016-2021)
3.5 Manufacturers Organ Transplant Immunosuppressant Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Organ Transplant Immunosuppressant Market Size by Type
4.1 Global Organ Transplant Immunosuppressant Historic Market Review by Type (2016-2021)
4.1.1 Global Organ Transplant Immunosuppressant Sales Market Share by Type (2016-2021)
4.1.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Type (2016-2021)
4.1.3 Global Organ Transplant Immunosuppressant Price by Type (2016-2021)
4.2 Global Organ Transplant Immunosuppressant Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Organ Transplant Immunosuppressant Sales Forecast by Type (2022-2027)
4.2.2 Global Organ Transplant Immunosuppressant Revenue Forecast by Type (2022-2027)
4.2.3 Global Organ Transplant Immunosuppressant Price Forecast by Type (2022-2027)
5 Global Organ Transplant Immunosuppressant Market Size by Application
5.1 Global Organ Transplant Immunosuppressant Historic Market Review by Application (2016-2021)
5.1.1 Global Organ Transplant Immunosuppressant Sales Market Share by Application (2016-2021)
5.1.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Application (2016-2021)
5.1.3 Global Organ Transplant Immunosuppressant Price by Application (2016-2021)
5.2 Global Organ Transplant Immunosuppressant Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Organ Transplant Immunosuppressant Sales Forecast by Application (2022-2027)
5.2.2 Global Organ Transplant Immunosuppressant Revenue Forecast by Application (2022-2027)
5.2.3 Global Organ Transplant Immunosuppressant Price Forecast by Application (2022-2027)

6 North America Organ Transplant Immunosuppressant Market Facts & Figures
6.1 North America Organ Transplant Immunosuppressant Sales by Company
6.1.1 North America Organ Transplant Immunosuppressant Sales by Company (2016-2021)
6.1.2 North America Organ Transplant Immunosuppressant Revenue by Company (2016-2021)
6.2 North America Organ Transplant Immunosuppressant Sales Breakdown by Type
6.2.1 North America Organ Transplant Immunosuppressant Sales Breakdown by Type (2016-2021)
6.2.2 North America Organ Transplant Immunosuppressant Sales Breakdown by Type (2022-2027)
6.3 North America Organ Transplant Immunosuppressant Sales Breakdown by Application
6.3.1 North America Organ Transplant Immunosuppressant Sales Breakdown by Application (2016-2021)
6.3.2 North America Organ Transplant Immunosuppressant Sales Breakdown by Application (2022-2027)

7 Europe Organ Transplant Immunosuppressant Market Facts & Figures
7.1 Europe Organ Transplant Immunosuppressant Sales by Company
7.1.1 Europe Organ Transplant Immunosuppressant Sales by Company (2016-2021)
7.1.2 Europe Organ Transplant Immunosuppressant Revenue by Company (2016-2021)
7.2 Europe Organ Transplant Immunosuppressant Sales Breakdown by Type
7.2.1 Europe Organ Transplant Immunosuppressant Sales Breakdown by Type (2016-2021)
7.2.2 Europe Organ Transplant Immunosuppressant Sales Breakdown by Type (2022-2027)
7.3 Europe Organ Transplant Immunosuppressant Sales Breakdown by Application
7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)

8 China Organ Transplant Immunosuppressant Market Facts & Figures
8.1 China Organ Transplant Immunosuppressant Sales by Company
8.1.1 China Organ Transplant Immunosuppressant Sales by Company (2016-2021)
8.1.2 China Organ Transplant Immunosuppressant Revenue by Company (2016-2021)
8.2 China Organ Transplant Immunosuppressant Sales Breakdown by Type
8.2.1 China Organ Transplant Immunosuppressant Sales Breakdown by Type (2016-2021)
8.2.2 China Organ Transplant Immunosuppressant Sales Breakdown by Type (2022-2027)
8.3 China Organ Transplant Immunosuppressant Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)

9 Japan Organ Transplant Immunosuppressant Market Facts & Figures
9.1 Japan Organ Transplant Immunosuppressant Sales by Company
9.1.1 Japan Organ Transplant Immunosuppressant Sales by Company (2016-2021)
9.1.2 Japan Organ Transplant Immunosuppressant Revenue by Company (2016-2021)
9.2 Japan Organ Transplant Immunosuppressant Sales Breakdown by Type
9.2.1 Japan Organ Transplant Immunosuppressant Sales Breakdown by Type (2016-2021)
9.2.2 Japan Organ Transplant Immunosuppressant Sales Breakdown by Type (2022-2027)
9.3 Japan Organ Transplant Immunosuppressant Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Organ Transplant Immunosuppressant Market Facts & Figures
10.1 Southeast Asia Organ Transplant Immunosuppressant Sales by Company
10.1.1 Southeast Asia Organ Transplant Immunosuppressant Sales by Company (2016-2021)
10.1.2 Southeast Asia Organ Transplant Immunosuppressant Revenue by Company (2016-2021)
10.2 Southeast Asia Organ Transplant Immunosuppressant Sales Breakdown by Type
10.2.1 Southeast Asia Organ Transplant Immunosuppressant Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Organ Transplant Immunosuppressant Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Organ Transplant Immunosuppressant Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Organ Transplant Immunosuppressant Market Facts & Figures
11.1 India Organ Transplant Immunosuppressant Sales by Company
11.1.1 India Organ Transplant Immunosuppressant Sales by Company (2016-2021)
11.1.2 India Organ Transplant Immunosuppressant Revenue by Company (2016-2021)
11.2 India Organ Transplant Immunosuppressant Sales Breakdown by Type
11.2.1 India Organ Transplant Immunosuppressant Sales Breakdown by Type (2016-2021)
11.2.2 India Organ Transplant Immunosuppressant Sales Breakdown by Type (2022-2027)
11.3 India Organ Transplant Immunosuppressant Sales Breakdown by Application
11.3.1 India Organ Transplant Immunosuppressant Sales Breakdown by Application (2016-2021)
11.3.2 India Organ Transplant Immunosuppressant Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Organ Transplant Immunosuppressant Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Organ Transplant Immunosuppressant Products Offered
12.1.5 Roche Recent Development
12.2 Astellas Pharma Inc.
12.2.1 Astellas Pharma Inc. Corporation Information
12.2.2 Astellas Pharma Inc. Business Overview
12.2.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Astellas Pharma Inc. Organ Transplant Immunosuppressant Products Offered
12.2.5 Astellas Pharma Inc. Recent Development
12.3 Huadong Pharmaceutical
12.3.1 Huadong Pharmaceutical Corporation Information
12.3.2 Huadong Pharmaceutical Business Overview
12.3.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Huadong Pharmaceutical Organ Transplant Immunosuppressant Products Offered
12.3.5 Huadong Pharmaceutical Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Organ Transplant Immunosuppressant Products Offered
12.4.5 Novartis Recent Development
12.5 Catalent Pharma
12.5.1 Catalent Pharma Corporation Information
12.5.2 Catalent Pharma Business Overview
12.5.3 Catalent Pharma Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Catalent Pharma Organ Transplant Immunosuppressant Products Offered
12.5.5 Catalent Pharma Recent Development
12.6 Cinkate Corporation
12.6.1 Cinkate Corporation Corporation Information
12.6.2 Cinkate Corporation Business Overview
12.6.3 Cinkate Corporation Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cinkate Corporation Organ Transplant Immunosuppressant Products Offered
12.6.5 Cinkate Corporation Recent Development
12.7 Cilag
12.7.1 Cilag Corporation Information
12.7.2 Cilag Business Overview
12.7.3 Cilag Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cilag Organ Transplant Immunosuppressant Products Offered
12.7.5 Cilag Recent Development
12.8 Genzyme
12.8.1 Genzyme Corporation Information
12.8.2 Genzyme Business Overview
12.8.3 Genzyme Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Genzyme Organ Transplant Immunosuppressant Products Offered
12.8.5 Genzyme Recent Development
12.9 Changzhou Pharm
12.9.1 Changzhou Pharm Corporation Information
12.9.2 Changzhou Pharm Business Overview
12.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Changzhou Pharm Organ Transplant Immunosuppressant Products Offered
12.9.5 Changzhou Pharm Recent Development
12.10 North China Pharmaceutical Group Corporation
12.10.1 North China Pharmaceutical Group Corporation Corporation Information
12.10.2 North China Pharmaceutical Group Corporation Business Overview
12.10.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.10.4 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Products Offered
12.10.5 North China Pharmaceutical Group Corporation Recent Development
12.11 SL PHARM
12.11.1 SL PHARM Corporation Information
12.11.2 SL PHARM Business Overview
12.11.3 SL PHARM Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.11.4 SL PHARM Organ Transplant Immunosuppressant Products Offered
12.11.5 SL PHARM Recent Development
12.12 Livzon Pharmaceutical Group Inc.,
12.12.1 Livzon Pharmaceutical Group Inc., Corporation Information
12.12.2 Livzon Pharmaceutical Group Inc., Business Overview
12.12.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Products Offered
12.12.5 Livzon Pharmaceutical Group Inc., Recent Development
12.13 Sirio Pharma Co., Ltd
12.13.1 Sirio Pharma Co., Ltd Corporation Information
12.13.2 Sirio Pharma Co., Ltd Business Overview
12.13.3 Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Products Offered
12.13.5 Sirio Pharma Co., Ltd Recent Development

13 Organ Transplant Immunosuppressant Manufacturing Cost Analysis
13.1 Organ Transplant Immunosuppressant Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Organ Transplant Immunosuppressant
13.4 Organ Transplant Immunosuppressant Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Organ Transplant Immunosuppressant Distributors List
14.3 Organ Transplant Immunosuppressant Customers

15 Market Dynamics
15.1 Organ Transplant Immunosuppressant Market Trends
15.2 Organ Transplant Immunosuppressant Drivers
15.3 Organ Transplant Immunosuppressant Market Challenges
15.4 Organ Transplant Immunosuppressant Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Organ Transplant Immunosuppressant Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Organ Transplant Immunosuppressant Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Organ Transplant Immunosuppressant Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Organ Transplant Immunosuppressant Sales (K Units) by Region (2016-2021)
Table 5. Global Organ Transplant Immunosuppressant Sales Market Share by Region (2016-2021)
Table 6. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Organ Transplant Immunosuppressant Revenue Share by Region (2016-2021)
Table 8. Global Organ Transplant Immunosuppressant Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Organ Transplant Immunosuppressant Revenue Share Forecast by Region (2022-2027)
Table 12. Global Organ Transplant Immunosuppressant Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Organ Transplant Immunosuppressant Sales Share by Company (2016-2021)
Table 14. Global Organ Transplant Immunosuppressant Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Organ Transplant Immunosuppressant Revenue Share by Company (2016-2021)
Table 16. Global Organ Transplant Immunosuppressant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppressant as of 2020)
Table 17. Global Organ Transplant Immunosuppressant Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Organ Transplant Immunosuppressant Manufacturing Sites and Area Served
Table 19. Manufacturers Organ Transplant Immunosuppressant Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Organ Transplant Immunosuppressant Sales (K Units) by Type (2016-2021)
Table 22. Global Organ Transplant Immunosuppressant Sales Share by Type (2016-2021)
Table 23. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Organ Transplant Immunosuppressant Price (US$/Unit) by Type (2016-2021)
Table 25. Global Organ Transplant Immunosuppressant Sales Share by Type (2022-2027)
Table 26. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Organ Transplant Immunosuppressant Revenue Share by Type (2022-2027)
Table 28. Global Organ Transplant Immunosuppressant Price (US$/Unit) by Type (2022-2027)
Table 29. Global Organ Transplant Immunosuppressant Sales (K Units) by Application (2016-2021)
Table 30. Global Organ Transplant Immunosuppressant Sales Share by Application (2016-2021)
Table 31. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Organ Transplant Immunosuppressant Price (US$/Unit) by Application (2016-2021)
Table 33. Global Organ Transplant Immunosuppressant Sales (K Units) by Application (2022-2027)
Table 34. Global Organ Transplant Immunosuppressant Sales Share by Application (2022-2027)
Table 35. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Organ Transplant Immunosuppressant Revenue Share by Application (2022-2027)
Table 37. Global Organ Transplant Immunosuppressant Price (US$/Unit) by Application (2022-2027)
Table 38. North America Organ Transplant Immunosuppressant Sales (K Units) by Company (2016-2021)
Table 39. North America Organ Transplant Immunosuppressant Sales Market Share by Company (2016-2021)
Table 40. North America Organ Transplant Immunosuppressant Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Organ Transplant Immunosuppressant Revenue Market Share by Company (2016-2021)
Table 42. North America Organ Transplant Immunosuppressant Sales by Type (2016-2021) & (K Units)
Table 43. North America Organ Transplant Immunosuppressant Sales Market Share by Type (2016-2021)
Table 44. North America Organ Transplant Immunosuppressant Sales by Type (2022-2027) & (K Units)
Table 45. North America Organ Transplant Immunosuppressant Sales Market Share by Type (2022-2027)
Table 46. North America Organ Transplant Immunosuppressant Sales by Application (2016-2021) & (K Units)
Table 47. North America Organ Transplant Immunosuppressant Sales Market Share by Application (2016-2021)
Table 48. North America Organ Transplant Immunosuppressant Sales by Application (2022-2027) & (K Units)
Table 49. North America Organ Transplant Immunosuppressant Sales Market Share by Application (2022-2027)
Table 50. Europe Organ Transplant Immunosuppressant Sales (K Units) by Company (2016-2021)
Table 51. Europe Organ Transplant Immunosuppressant Sales Market Share by Company (2016-2021)
Table 52. Europe Organ Transplant Immunosuppressant Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Organ Transplant Immunosuppressant Revenue Market Share by Company (2016-2021)
Table 54. Europe Organ Transplant Immunosuppressant Sales by Type (2016-2021) & (K Units)
Table 55. Europe Organ Transplant Immunosuppressant Sales Market Share by Type (2016-2021)
Table 56. Europe Organ Transplant Immunosuppressant Sales by Type (2022-2027) & (K Units)
Table 57. Europe Organ Transplant Immunosuppressant Sales Market Share by Type (2022-2027)
Table 58. Europe Organ Transplant Immunosuppressant Sales by Application (2016-2021) & (K Units)
Table 59. Europe Organ Transplant Immunosuppressant Sales Market Share by Application (2016-2021)
Table 60. Europe Organ Transplant Immunosuppressant Sales by Application (2022-2027) & (K Units)
Table 61. Europe Organ Transplant Immunosuppressant Sales Market Share by Application (2022-2027)
Table 62. China Organ Transplant Immunosuppressant Sales (K Units) by Company (2016-2021)
Table 63. China Organ Transplant Immunosuppressant Sales Market Share by Company (2016-2021)
Table 64. China Organ Transplant Immunosuppressant Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Organ Transplant Immunosuppressant Revenue Market Share by Company (2016-2021)
Table 66. China Organ Transplant Immunosuppressant Sales by Type (2016-2021) & (K Units)
Table 67. China Organ Transplant Immunosuppressant Sales Market Share by Type (2016-2021)
Table 68. China Organ Transplant Immunosuppressant Sales by Type (2022-2027) & (K Units)
Table 69. China Organ Transplant Immunosuppressant Sales Market Share by Type (2022-2027)
Table 70. China Organ Transplant Immunosuppressant Sales by Application (2016-2021) & (K Units)
Table 71. China Organ Transplant Immunosuppressant Sales Market Share by Application (2016-2021)
Table 72. China Organ Transplant Immunosuppressant Sales by Application (2022-2027) & (K Units)
Table 73. China Organ Transplant Immunosuppressant Sales Market Share by Application (2022-2027)
Table 74. Japan Organ Transplant Immunosuppressant Sales (K Units) by Company (2016-2021)
Table 75. Japan Organ Transplant Immunosuppressant Sales Market Share by Company (2016-2021)
Table 76. Japan Organ Transplant Immunosuppressant Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Organ Transplant Immunosuppressant Revenue Market Share by Company (2016-2021)
Table 78. Japan Organ Transplant Immunosuppressant Sales by Type (2016-2021) & (K Units)
Table 79. Japan Organ Transplant Immunosuppressant Sales Market Share by Type (2016-2021)
Table 80. Japan Organ Transplant Immunosuppressant Sales by Type (2022-2027) & (K Units)
Table 81. Japan Organ Transplant Immunosuppressant Sales Market Share by Type (2022-2027)
Table 82. Japan Organ Transplant Immunosuppressant Sales by Application (2016-2021) & (K Units)
Table 83. Japan Organ Transplant Immunosuppressant Sales Market Share by Application (2016-2021)
Table 84. Japan Organ Transplant Immunosuppressant Sales by Application (2022-2027) & (K Units)
Table 85. Japan Organ Transplant Immunosuppressant Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Organ Transplant Immunosuppressant Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Organ Transplant Immunosuppressant Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Organ Transplant Immunosuppressant Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Organ Transplant Immunosuppressant Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Organ Transplant Immunosuppressant Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Organ Transplant Immunosuppressant Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Organ Transplant Immunosuppressant Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Application (2022-2027)
Table 98. India Organ Transplant Immunosuppressant Sales (K Units) by Company (2016-2021)
Table 99. India Organ Transplant Immunosuppressant Sales Market Share by Company (2016-2021)
Table 100. India Organ Transplant Immunosuppressant Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Organ Transplant Immunosuppressant Revenue Market Share by Company (2016-2021)
Table 102. India Organ Transplant Immunosuppressant Sales by Type (2016-2021) & (K Units)
Table 103. India Organ Transplant Immunosuppressant Sales Market Share by Type (2016-2021)
Table 104. India Organ Transplant Immunosuppressant Sales by Type (2022-2027) & (K Units)
Table 105. India Organ Transplant Immunosuppressant Sales Market Share by Type (2022-2027)
Table 106. India Organ Transplant Immunosuppressant Sales by Application (2016-2021) & (K Units)
Table 107. India Organ Transplant Immunosuppressant Sales Market Share by Application (2016-2021)
Table 108. India Organ Transplant Immunosuppressant Sales by Application (2022-2027) & (K Units)
Table 109. India Organ Transplant Immunosuppressant Sales Market Share by Application (2022-2027)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Roche Organ Transplant Immunosuppressant Product
Table 114. Roche Recent Development
Table 115. Astellas Pharma Inc. Corporation Information
Table 116. Astellas Pharma Inc. Description and Business Overview
Table 117. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Astellas Pharma Inc. Organ Transplant Immunosuppressant Product
Table 119. Astellas Pharma Inc. Recent Development
Table 120. Huadong Pharmaceutical Corporation Information
Table 121. Huadong Pharmaceutical Description and Business Overview
Table 122. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Huadong Pharmaceutical Organ Transplant Immunosuppressant Product
Table 124. Huadong Pharmaceutical Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Novartis Organ Transplant Immunosuppressant Product
Table 129. Novartis Recent Development
Table 130. Catalent Pharma Corporation Information
Table 131. Catalent Pharma Description and Business Overview
Table 132. Catalent Pharma Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Catalent Pharma Organ Transplant Immunosuppressant Product
Table 134. Catalent Pharma Recent Development
Table 135. Cinkate Corporation Corporation Information
Table 136. Cinkate Corporation Description and Business Overview
Table 137. Cinkate Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Cinkate Corporation Organ Transplant Immunosuppressant Product
Table 139. Cinkate Corporation Recent Development
Table 140. Cilag Corporation Information
Table 141. Cilag Description and Business Overview
Table 142. Cilag Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Cilag Organ Transplant Immunosuppressant Product
Table 144. Cilag Recent Development
Table 145. Genzyme Corporation Information
Table 146. Genzyme Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Genzyme Description and Business Overview
Table 148. Genzyme Organ Transplant Immunosuppressant Product
Table 149. Genzyme Recent Development
Table 150. Changzhou Pharm Corporation Information
Table 151. Changzhou Pharm Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Changzhou Pharm Description and Business Overview
Table 153. Changzhou Pharm Organ Transplant Immunosuppressant Product
Table 154. Changzhou Pharm Recent Development
Table 155. North China Pharmaceutical Group Corporation Corporation Information
Table 156. North China Pharmaceutical Group Corporation Description and Business Overview
Table 157. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product
Table 159. North China Pharmaceutical Group Corporation Recent Development
Table 160. SL PHARM Corporation Information
Table 161. SL PHARM Description and Business Overview
Table 162. SL PHARM Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. SL PHARM Organ Transplant Immunosuppressant Product
Table 164. SL PHARM Recent Development
Table 165. Livzon Pharmaceutical Group Inc., Corporation Information
Table 166. Livzon Pharmaceutical Group Inc., Description and Business Overview
Table 167. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product
Table 169. Livzon Pharmaceutical Group Inc., Recent Development
Table 170. Sirio Pharma Co., Ltd Corporation Information
Table 171. Sirio Pharma Co., Ltd Description and Business Overview
Table 172. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Product
Table 174. Sirio Pharma Co., Ltd Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Organ Transplant Immunosuppressant Distributors List
Table 178. Organ Transplant Immunosuppressant Customers List
Table 179. Organ Transplant Immunosuppressant Market Trends
Table 180. Organ Transplant Immunosuppressant Market Drivers
Table 181. Organ Transplant Immunosuppressant Market Challenges
Table 182. Organ Transplant Immunosuppressant Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Immunosuppressant Product Picture
Figure 2. Global Organ Transplant Immunosuppressant Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Organ Transplant Immunosuppressant Sales Market Share by Application in 2021 & 2027
Figure 6. Liver Transplant Examples
Figure 7. Kidney Transplant Examples
Figure 8. Heart Transplant Examples
Figure 9. Other Organ Transplant Examples
Figure 10. Global Organ Transplant Immunosuppressant Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Organ Transplant Immunosuppressant Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Organ Transplant Immunosuppressant Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Organ Transplant Immunosuppressant Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 14. Global Organ Transplant Immunosuppressant Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Organ Transplant Immunosuppressant Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Organ Transplant Immunosuppressant Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Organ Transplant Immunosuppressant Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Organ Transplant Immunosuppressant Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Organ Transplant Immunosuppressant Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Organ Transplant Immunosuppressant Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Organ Transplant Immunosuppressant Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Organ Transplant Immunosuppressant Players Market Share by Revenue in Organ Transplant Immunosuppressant: 2016 & 2020
Figure 29. Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Organ Transplant Immunosuppressant Revenue Share by Type (2016-2021)
Figure 31. Global Organ Transplant Immunosuppressant Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Organ Transplant Immunosuppressant Revenue Share by Application (2016-2021)
Figure 33. Global Organ Transplant Immunosuppressant Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Organ Transplant Immunosuppressant Sales Market Share by Type in 2020
Figure 35. North America Organ Transplant Immunosuppressant Sales Market Share by Application in 2020
Figure 36. Europe Organ Transplant Immunosuppressant Sales Market Share by Type in 2020
Figure 37. Europe Organ Transplant Immunosuppressant Sales Market Share by Application in 2020
Figure 38. China Organ Transplant Immunosuppressant Sales Market Share by Type in 2020
Figure 39. China Organ Transplant Immunosuppressant Sales Market Share by Application in 2020
Figure 40. Japan Organ Transplant Immunosuppressant Sales Market Share by Type in 2020
Figure 41. Japan Organ Transplant Immunosuppressant Sales Market Share by Application in 2020
Figure 42. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Type in 2020
Figure 43. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Application in 2020
Figure 44. India Organ Transplant Immunosuppressant Sales Market Share by Type in 2020
Figure 45. India Organ Transplant Immunosuppressant Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Organ Transplant Immunosuppressant
Figure 48. Manufacturing Process Analysis of Organ Transplant Immunosuppressant
Figure 49. Organ Transplant Immunosuppressant Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed


【掲載企業】

Roche、Astellas Pharma Inc.、Huadong Pharmaceutical、Novartis、Catalent Pharma、Cinkate Corporation、Cilag、Genzyme、Changzhou Pharm、North China Pharmaceutical Group Corporation、SL PHARM、Livzon Pharmaceutical Group Inc.,、Sirio Pharma Co., Ltd

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 臓器移植用免疫抑制薬の世界市場2021年(Global Organ Transplant Immunosuppressant Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆